Citadel Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-41,717
| Closed | -$467K | – | 4574 |
|
|
2017
Q3 | $467K | Hold |
41,717
| – | – | ﹤0.01% | 2735 |
|
|
2017
Q2 | $459K | Hold |
41,717
| – | – | ﹤0.01% | 2649 |
|
|
2017
Q1 | $409K | Hold |
41,717
| – | – | ﹤0.01% | 2727 |
|
|
2016
Q4 | $451K | Sell |
41,717
-690
| -2% | -$7.46K | ﹤0.01% | 2550 |
|
|
2016
Q3 | $435K | Buy |
42,407
+1,400
| +3% | +$14.4K | ﹤0.01% | 2532 |
|
|
2016
Q2 | $536K | Buy |
41,007
+19,610
| +92% | +$256K | ﹤0.01% | 2196 |
|
|
2016
Q1 | $235K | Buy |
+21,397
| New | +$235K | ﹤0.01% | 2627 |
|
|
2015
Q3 | – | Sell |
-43,707
| Closed | -$429K | – | 4482 |
|
|
2015
Q2 | $429K | Sell |
43,707
-170,756
| -80% | -$1.68M | ﹤0.01% | 2658 |
|
|
2015
Q1 | $1.9M | Buy |
214,463
+93,768
| +78% | +$831K | ﹤0.01% | 1832 |
|
|
2014
Q4 | $1.06M | Buy |
120,695
+27,761
| +30% | +$243K | ﹤0.01% | 2081 |
|
|
2014
Q3 | $640K | Sell |
92,934
-12,120
| -12% | -$83.5K | ﹤0.01% | 2296 |
|
|
2014
Q2 | $552K | Sell |
105,054
-85,604
| -45% | -$450K | ﹤0.01% | 2218 |
|
|
2014
Q1 | $867K | Buy |
190,658
+72,329
| +61% | +$329K | ﹤0.01% | 1944 |
|
|
2013
Q4 | $596K | Buy |
+118,329
| New | +$596K | ﹤0.01% | 1941 |
|
|
2013
Q3 | – | Sell |
-11,594
| Closed | -$58K | – | 3157 |
|
|
2013
Q2 | $58K | Buy |
+11,594
| New | +$58K | ﹤0.01% | 2516 |
|